[Evidence-based pharmacoanalytics of using venlafaxine in clinical medicine].
Rachin
A P
AP
Sergeev
A V
AV
D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage / Q000627:therapeutic use*; D015510:Clinical Medicine; D003511:Cyclohexanols / Q000008:administration & dosage / Q000627:therapeutic use*; D003627:Data Interpretation, Statistical; D019317:Evidence-Based Medicine; D006801:Humans; D010919:Placebos; D016032:Randomized Controlled Trials as Topic; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors; D000069470:Venlafaxine Hydrochloride
D018687:Antidepressive Agents, Second-Generation; D003511:Cyclohexanols; D010919:Placebos; D017367:Selective Serotonin Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride